Ligand Set For Partnership Opportunities After Completing On Pfenex

Sets Out Strategy And Revenue Drivers After Finalizing $500m Deal

 
• By David Wallace
  
Open doors
The Pfenex deal opens the door to at least three new partnerships in the next 12 months, Ligand says • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business